According to a new report by Expert Market Research titled “Global Peripheral Artery Disease Market Demand, Share, Analysis, Report, Size, Forecast 2023-2028″, the global peripheral artery disease market is expected to grow from USD 4.45 billion in 2022 to USD 6.4 billion by 2028, at a CAGR of 6.35%. The growth of the market is driven by the increasing prevalence of PAD, the rising incidence of risk factors for PAD, and the development of new treatment options.
Peripheral artery disease (PAD) is a condition that occurs when the arteries that carry blood to the limbs become narrowed or blocked. This can reduce blood flow to the legs and feet, and can cause a variety of symptoms, including pain, numbness, and cramping. PAD is a serious condition that can lead to amputation if it is not treated.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/peripheral-artery-disease-market/requestsample
Prevalence of PAD
PAD is a common condition, affecting an estimated 200 million people worldwide. The prevalence of PAD increases with age, and it is more common in men than women. PAD is also more common in people with certain risk factors, such as smoking, diabetes, and high blood pressure.
Risk Factors for PAD
The risk factors for PAD include:
- High blood pressure
- High cholesterol
- Family history of PAD
- Physical inactivity
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/peripheral-artery-disease-market
Treatment Options for PAD
The treatment for PAD depends on the severity of the condition. Mild PAD may be treated with lifestyle changes, such as smoking cessation, exercise, and a healthy diet. More severe PAD may require medication or surgery.
The following lifestyle changes can help to reduce the risk of PAD and improve symptoms:
- Quit smoking
- Exercise regularly
- Eat a healthy diet
- Maintain a healthy weight
- Control blood pressure
- Control cholesterol
Medications that can be used to treat PAD include:
Surgery may be necessary to treat PAD if lifestyle changes and medication are not effective. The following surgical procedures may be used to treat PAD:
- Stent placement
The Future of the Peripheral Artery Disease Market
The future of the peripheral artery disease market is expected to be driven by the development of new treatment options. Researchers are working on developing new drugs and devices that can improve the treatment of PAD. Additionally, the increasing awareness of PAD among healthcare professionals and patients is expected to drive the growth of the market.
Key Players in the Peripheral Artery Disease Market
The key players in the peripheral artery disease market include:
- Abbott Laboratories
- Boston Scientific Corporation
- Cordis Corporation
- Terumo Corporation
Q: What is Peripheral Artery Disease (PAD)?
A: Peripheral Artery Disease (PAD) is a circulatory disorder caused by the narrowing or blockage of arteries that supply blood to the legs and feet.
Q: What are the major risk factors for PAD?
A: The major risk factors for PAD include smoking, diabetes, high blood pressure, high cholesterol levels, family history of PAD, and advancing age.
Q: What are the common symptoms of PAD?
A: Common symptoms of PAD include leg pain or cramping, especially during physical activity, numbness or weakness in the legs, slow-healing sores on the legs or feet, and coldness or discoloration of the legs or feet.
Q: How is PAD diagnosed?
A: PAD is diagnosed through a physical exam and several diagnostic tests such as ankle-brachial index (ABI), Doppler ultrasound, and angiography.
Q: What is the current market size of the Peripheral Artery Disease Market?
A: According to a report by Expert Market Research, the global peripheral artery disease market is expected to grow from USD 4.45 billion in 2022 to USD 6.4 billion by 2028, at a CAGR of 6.35%.
Q: What are the major treatment options for PAD?
A: The major treatment options for PAD include lifestyle changes such as quitting smoking, regular exercise, and healthy diet, medications such as antiplatelets and anticoagulants, and procedures such as angioplasty and bypass surgery.
Q: What is the current trend in the Peripheral Artery Disease market?
A: The current trend in the Peripheral Artery Disease market is the development of advanced minimally invasive procedures such as atherectomy, thrombectomy, and drug-coated balloons.
Q: What is the major driver of growth in the Peripheral Artery Disease market?
A: The major driver of growth in the Peripheral Artery Disease market is the increasing prevalence of the disease due to the growing aging population and the rising prevalence of risk factors such as diabetes and obesity.
Q: Which region is expected to dominate the Peripheral Artery Disease market during the forecast period?
A: North America is expected to dominate the Peripheral Artery Disease market during the forecast period due to the high prevalence of PAD in the region, the presence of major market players, and the increasing adoption of advanced treatment options.
Q: Who are the major players in the Peripheral Artery Disease market?
A: The major players in the Peripheral Artery Disease market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, and Terumo Corporation, among others.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Edward Dugger, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA